Alzheimer’s Disease Diagnostic Market is Predicted to Reach USD 12 billion by 2022

Alzheimer’s Disease Diagnostic Market Analysis

As per Market Research Future (MRFR) analysis, the global Alzheimer’s disease diagnostic market is estimated to reach USD 12 billion with a CAGR of 10% from 2016 to 2022 (forecast period).

Alzheimer's is a kind of dementia that results in memory loss combined with thinking and behavioral problems. Alzheimer's is a progressive disease as it grows gradually over time and damages the maximum part of the brain that finally destroys brain cells. Alzheimer's disease (AD) is the most common cause of progressive dementia in the elderly. There has been an unprecedented growth in the number of cases of Alzheimer's disease globally, highlighting the need for effective treatment. According to the Alzheimer's Association, an estimated 5.4 million Americans of all ages had Alzheimer's disease in 2016. One in nine people aged 65 and over has Alzheimer's disease. In 2050, the number of people aged 65 and over with Alzheimer's disease is projected to almost increase from 5.2 million to 13.8 million, without medical advancements to prevent or cure the disease. Mortality levels due to Alzheimer's disease are relatively high. Between 2000 and 2013, heart, stroke, and prostate cancer deaths decreased by 14%, 23%, and 11%, respectively, while AD deaths rose by 71% in the US. Likewise, according to Alzheimer's disease International, an estimated 46.8 million people worldwide were living with dementia in 2015 and are expected to rise in the future. As a result, the market for Alzheimer's Diagnostics is growing worldwide.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/2149

Alzheimer’s Disease Diagnostic Market Dynamics

Globally, the aging population is a primary factor of Alzheimer's disease diagnostics market. Rising life expectancy leads to a significant rise in the number of older people and is associated with an increase in the prevalence of chronic diseases such as dementia. Alzheimer's disease treatments provide temporary and uncertain improvements in the well-being of individuals, and none of the approved medications can change the progression of the disease. Therefore, the magnitude of the affected population and the lack of adequate and effective treatment presents an enormous opportunity for drug manufacturers. However, the identification of the primary reasons and mechanisms involved in Alzheimer's disease is minimal. Drug manufacturers have been unable to demonstrate substantial clinical benefits of treatment for various new compounds due to stringent regulations. The collaboration of emerging players is one of the significant trends observed in this market.

Alzheimer’s Disease Diagnostic Market Segmentation

The global market for Alzheimer’s disease diagnostic has been segmented into type, diagnostic tests, and end-users.

Based on type, the global market for Alzheimer’s disease diagnostic has been segmented into early-onset Alzheimer's disease, familial Alzheimer's disease, late-onset Alzheimer's disease, and more.

Based on diagnostic tests, the global market for Alzheimer’s disease diagnostic has been segmented into genetic testing, mini-mental state exam (MMSE), neurological exam, brain imaging, and others.

Based on end-users, the global market for Alzheimer’s disease diagnostic has been segmented into clinics, hospitals, diagnostic centers, and others.

Alzheimer’s Disease Diagnostic Market Regional Analysis

Region-wise, the global market for Alzheimer’s disease diagnostic has been segmented into North America, Europe, Asia Pacific and the Middle East & Africa.

North America had the highest market share in the global market for Alzheimer's disease diagnostic in 2015. Alzheimer's disease diagnostic market in North America is expected to hit USD 12 million by the end of the forecast period. The rise in the market is due to the increasing prevalence of Alzheimer's disease with an increase in the aging population and significant technological advancements in the field.

Europe is the second-largest market for Alzheimer's disease diagnostic.

The Asia Pacific is predicted to be the fastest-growing Alzheimer's disease diagnostic market.

Alzheimer’s Disease Diagnostic Market Key Players

Some of the key players identified by MRFR in this market are Eli Lilly and Company (UK), Alector LLC (US), TauRx (Republic of Singapore), Accera, Inc. (US), Neuro-Bio Ltd (UK), Treventis Corporation (US), Cognition Therapeutics Inc. (US) and others.

Ask Questions To The Experts @ https://www.marketresearchfuture.com/enquiry/2149

Table Of Content

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

...TOC Continued

List Of Tables

TABLE 1 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, 2013-2022 (USD MILLION)

TABLE 2 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY TYPE, 2013-2022 (USD MILLION)

TABLE 3 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY DIAGNOSTICS TYPE, 2013-2022 (USD MILLION)

TABLE 4 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY END USERS, 2013-2022 (USD MILLION)

TABLE 5 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY REGION, 2013-2022 (USD MILLION)

...Continued

List Of Figures

FIGURE 1 RESEARCH PROCESS

FIGURE 2 PORTERS FIVE FORCES MODEL

FIGURE 3 GLOBAL ORTHOPEDIC TRAUMA DEVICE SMARKET, BY TYPE

FIGURE 4 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY DIAGNOSTICS TYPE

FIGURE 5 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY END USERS

FIGURE 6 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY REGION

FIGURE 7 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET: COMPANY SHARE ANALYSIS, 2015 (%)

...Continued

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/alzheimers-disease-diagnostic-market-2149

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

This release was published on openPR.